AwardTape · Defense awards · Research and development · Defense systems R&D · HDTRA118C0031
HDTRA118C0031: $0 definitive contract to Genecapture, Inc
Genecapture, Inc holds a definitive contract from Defense Threat Reduction Agency with $0 obligated since Oct 2023 and $1.3M obligated over its life, against a ceiling of $1.3M. Latest action Jul 17, 2025.
C2-0482 sttr phase ii
| PIID | HDTRA118C0031 |
|---|---|
| Type | definitive contract |
| Company | Genecapture, Inc |
| Agency | Defense Threat Reduction Agency |
| Contracting office | DEFENSE THREAT REDUCTION AGENCY |
| Category | Research and development · Defense systems R&D |
| PSC | AD95 OTHER DEFENSE (OPERATIONAL) |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $1.3M |
| Ceiling (base and all options) | $1.3M |
| Base date | Mar 16, 2018 |
| Latest action | Jul 17, 2025 |
| End date | Sep 15, 2020 |
| Actions since Oct 2023 | 2 |
| Pricing | Cost plus fixed fee |
| Competition | Competed after exclusion of sources |
| Place of performance | AL |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial